Table of Contents  by unknown
Editorials 285 Endovascular stenting for descending aneurysms: Wave of the future or the
emperor’s new clothes? Œ
John A. Elefteriades, MD, and Andrew Percy, New Haven, Conn
289 Incidence of ventricular arrhythmias after left ventricular reconstructive
surgery f
Marisa Di Donato, MD, Michel Sabatier, MD, Lorenzo Menicanti, MD, and Vincent Dor, MD,
Milan and Florence, Italy
292 Reply to Di Donato and colleagues f
James O. O’Neill, FRCPI, Randall C. Starling, FACC, MPH, and Mina K. Chung, FACC,
Cleveland, Ohio, and Dublin, Ireland
294 Percutaneous aortic valve replacement: Which patients are suitable for it? A
quest for a controlled use 
Francesca di Marco, MD and Gino Gerosa, MD, Padova, Italy
299 Percutaneous aortic valve replacement 
Bruce W. Lytle, MD, Cleveland, Ohio
300 Beyond disclosure: Managing conflicts of interest to strengthen trust in our
profession
Martin F. McKneally, MD, Toronto, Ontario, Canada
General Thoracic
Surgery (GTS)
303 Data acquisition for the histoculture drug response assay in lung cancer
Tatsuya Yoshimasu, MD, PhD, Shoji Oura, MD, PhD, Issei Hirai, MD, PhD,
Takeshi Tamaki, MD, Yozo Kokawa, MD, PhD, Kazuhito Hata, MD, Fuminori Ohta, MD,
Rie Nakamura, MD, Mitsumasa Kawago, MD, Hirokazu Tanino, MD, PhD,
Yoshitaka Okamura, MD, PhD, and Tomoko Furukawa, MD, PhD, Wakayama and Tokyo, Japan
Application of the histoculture drug response assay (HDRA) for lung cancer was investigated
by using data acquired from 359 lung cancer specimens in a single institute. The evaluability of
HDRA was high at 97.4%. Good predictability, including true-positive and true-negative rates
of 73.2% and 100%, was observed. The HDRA appears to be applicable to non–small cell lung
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309 Differential vascular growth in postpneumonectomy compensatory lung
growth
Lucas G. Fernandez, MD, DSc, Timothy D. Le Cras, PhD, Mirta Ruiz, MD,
David K. Glover, PhD, Irving L. Kron, MD, and Victor E. Laubach, PhD, Charlottesville,
Va, and Cincinnati, Ohio
Left pneumonectomy induces nonuniform compensatory growth in the lobes of the right lung.
Vascular growth and cell proliferation were preferentially increased in the upper lobe, which
correlated with higher relative blood flow.
317 T2N0M0 esophageal cancer
Thomas W. Rice, MD, David P. Mason, MD, Sudish C. Murthy, MD, PhD,
Gregory Zuccaro Jr., MD, David J. Adelstein, MD, Lisa A. Rybicki, MS, and
Eugene H. Blackstone, MD, Cleveland, Ohio
Decision making in stage-directed therapy of esophageal cancer is easy at the extremes of stage
groupings, but is guesswork for uncommon intermediate cancers such as T2N0M0, which
require balancing incorrect clinical staging with toxic overtreatment. Because most cT2N0M0
cancers are overstaged, treatment should be esophagectomy first followed by postoperative
adjuvant therapy if understaged.
325 The Thoracic Surgery Scoring System (Thoracoscore): Risk model for in-
hospital death in 15,183 patients requiring thoracic surgery
Pierre Emmanuel Falcoz, MD, PhD, Massimo Conti, MD, Laurent Brouchet, MD,
Sidney Chocron, MD, PhD, Marc Puyraveau, BSc, Mariette Mercier, MD, PhD,
Joseph Philippe Etievent, MD, and Marcel Dahan, MD, Besanc¸on, Lille, and Toulouse, France
The risk model presented in this study was developed with national data, uses only 9 variables,
and has good performance characteristics. It appears to be a valid clinical tool for predicting
the risk of in-hospital death for adult patients requiring general thoracic surgery.
333 Postoperative esophageal leak management with the Polyflex esophageal
stent
Richard K. Freeman, MD, Anthony J. Ascioti, MD, and Thomas C. Wozniak, MD,
Indiannapolis, Ind
Leak after esophageal anastomosis or perforation can be a challenge to treat. This review
demonstrates the effectiveness of treating postoperative esophageal leaks endoscopically with
an occlusive silicone stent.
339 Experimental safety and efficacy evaluation of an extracorporeal pumpless
artificial lung in providing respiratory support through the axillary vessels
Manuela Iglesias, MD, Philipp Jungebluth, Oriol Sibila, MD, Ivete Aldabo, RN,
Marı´a Purificacio´n Matute, MD, Carole Petit, RN, Antoni Torres, MD, and
Paolo Macchiarini, MD, PhD, Barcelona, Spain
A pumpless artificial lung attached to the axillary vessels by means of graft interposition
shunted less blood flow than direct cannulation (approximately 13% vs 31% of the cardiac
output) in pigs and provided full gas exchange support during apneic ventilation (tidal volume,
1-2 mL/kg) with less hemodynamic instability.
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346 Management of pleural space infections: A population-based analysis
Farhood Farjah, MD, Rebecca Gaston Symons, MPH, Bahirathan Krishnadasan, MD,
Douglas E. Wood, MD, and David R. Flum, MD, MPH, Seattle, Wash
A statewide administrative database investigation of pleural space infections occurring between
1987 and 2004 revealed an increasing incidence of disease, an increasing proportion of patients
undergoing operations, and an associated 58% reduction in the odds of early death for patients
undergoing operations after adjusting for age, sex, comorbidity index, and insurance status.
352 Chemotherapy resistance and oncogene expression in non–small cell lung
cancer
Thomas A. d‘Amato, MD, PhD, Rodney J. Landreneau, MD, William Ricketts, PhD,
Weidong Huang, MD, PhD, Ricardo Parker, PhD, Eugene Mechetner, MD, Ing-Ru Yu, MS,
and James D. Luketich, MD, Philadelphia and Pittsburgh, Pa, and Tustin, Calif
In vitro chemotherapy resistance to common antineoplastic agents for NSCLC is prevalent.
Tumors exhibited simultaneous resistance to chemotherapy doublets in a cellular proliferation
assay. Molecular markers p53 and EGFR were associated resistance patterns for some drugs.
Integrating in vitro testing into clinical trials is warranted to validate these results.
364 The distribution of parenchyma, follicles, and lymphocyte subsets in thymus
of patients with myasthenia gravis, with special reference to remission after
thymectomy
Takeshi Mori, MD, Hiroaki Nomori, MD, PhD, Koei Ikeda, MD, PhD,
Hironori Kobayashi, MD, Kazunori Iwatani, MD, and Toshiaki Kobayashi, MD, PhD,
Kumamoto and Tokyo, Japan
In the thymus of patients with myasthenia gravis, the middle part had the largest parenchyma,
the highest grades of follicular hyperplasia, and the highest density of T-cell subsets, the latter




369 Endovascular stent grafting versus open surgical repair of descending
thoracic aortic aneurysms in low-risk patients: A multicenter comparative
trial Œ
Joseph E. Bavaria, MD, Jehangir J. Appoo, MD, Michel S. Makaroun, MD, Joel Verter, PhD,
Zi-Fan Yu, ScD, and R. Scott Mitchell, MD, for the Gore TAG Investigators, Philadelphia and
Pittsburgh, Pa, Calgary, Alberta, Canada, Washington, DC, and Stanford, Calif
Results from the first completed multicenter trial of endovascular repair versus open surgical
repair of descending thoracic aortic aneurysms are presented. Endografting resulted in
decreased perioperative mortality and spinal cord ischemia but an increased incidence of
reinterventions through 2 years’ follow-up.
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378 Coronary artery bypass grafting with or without cardiopulmonary bypass in
patients with preoperative non–dialysis dependent renal insufficiency: A
randomized study
Lokeswara Rao Sajja, MCh, FACS, Gopichand Mannam, FRCS (Ed), FRCS (CT),
Rajasekara M. Chakravarthi, MD, DNB, Sriramulu Sompalli, MD, Shanti K. Naidu, MD,
Bhupathiraju Somaraju, MD, DM, and Raghava Raju Penumatsa, MD, DM, Hyderabad, India
A randomized trial compared the deleterious effects of two techniques of surgical myocardial
revasularization with or without the use of CPB. Off-pump CABG is more renoprotective than
the on-pump technique, and the effect is more pronounced in diabetic patients.
389 The effect of ablation technology on surgical outcomes after the Cox-maze
procedure: A propensity analysis
Shelly C. Lall, MD, Spencer J. Melby, MD, Rochus K. Voeller, MD, Andreas Zierer, MD,
Marci S. Bailey, RN, Tracey J. Guthrie, RN, Marc R. Moon, MD, Nader Moazami, MD,
Jennifer S. Lawton, MD, and Ralph J. Damiano, Jr, MD, Saint Louis, Mo
The Cox-maze IV procedure, using bipolar radiofrequency abalation and cryoablation, was
compared with the traditional cut-and-sew Cox-maze III procedure. Comparing matched
populations, the operation was done with shorter crossclamp times and produced similar
surgical outcomes as the Cox-maze III procedure.
397 Sternal wound infection after coronary artery bypass graft surgery:
Validation of existing risk scores
Mical Paul, MD, Aeyal Raz, MD, PhD, Leonard Leibovici, MD, Hefziba Madar, RN,
Rita Holinger, RN, and Bina Rubinovitch, MD, Tel-Aviv, Israel
In a prospective cohort of 809 patients undergoing coronary artery bypass surgery, the
EuroSCORE and the Society of Thoracic Surgeons risk score predicted well both the
occurrence of sternal wound infections and all-cause mortality at 30 days and 6 months after
surgical intervention. The performance of the National Nosocomial Infections Surveillance risk
index was poorer.
404 Cardiac surgery after mediastinal radiation: Extent of exposure influences
outcome
Albert S. Y. Chang, MD, Nicholas G. Smedira, MD, Catherine L. Chang, MD,
Monica M. Benavides, BS, Ulf Myhre, MD, Jingyuan Feng, MS, Eugene H. Blackstone, MD,
and Bruce W. Lytle, MD, Cleveland, Ohio
Among patients undergoing cardiac surgery after thoracic radiation, radiation exposure is
heterogeneous, and therefore these patients cannot be managed and assessed as a single uniform
cohort. Extensively irradiated patients are more likely to have increased perioperative morbidity
and decreased short- and long-term survival relative to those receiving tangential radiation.
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414 Replacement of the ascending aorta with reduction of the diameter of the
sinotubular junction to treat aortic insufficiency in patients with ascending
aortic aneurysm
Tirone E. David, MD, Christopher M. Feindel, MD, Susan Armstrong, MSc, and
Manjula Maganti, MSc, Toronto, Ontario, Canada
Aneurysm of the ascending aorta often causes dilation of the STJ with consequent AI. A series
of 103 patients with this disease underwent surgery with correction of AI by reduction in the
diameter of the STJ. Valve function remained stable in most patients during the follow-up.
419 Catheter-based infrared light scanner as a tool to assess conduit quality in
coronary artery bypass surgery
Nicholas Burris, BS, Kimberly Schwartz, RNFA, MBA, Cha-Min Tang, MD, PhD,
M. Samir Jafri, PhD, Joseph Schmitt, PhD, Michael H. Kwon, BS, Ozeki Toshinaga, PhD,
Junyan Gu, MD, PhD, Jamie Brown, MD, Emile Brown, BS, Richard Pierson III, MD, and
Robert Poston, MD, Baltimore, Md, and Westford, Mass
Intimal integrity is critical for the proper function of a conduit as a bypass graft. We used a
novel, light-based imaging modality to assess the intima in the harvested radial artery and
saphenous vein. A wide array of pathologies was discovered in conduits considered clinically
suitable for grafting.
428 Central cannulation is safe in acute aortic dissection repair
T. Brett Reece, MD, Curtis G. Tribble, MD, Robert L. Smith, MD, R. Ramesh Singh, MD,
Brendon M. Stiles, Benjamin B. Peeler, MD, John A. Kern, MD, and Irving L. Kron, MD,
Charlottesville, Va
Cannulation of the ascending aorta in acute type A dissections remains controversial. This
study examines the safety of central cannulation while proposing an algorithm to the
cannulation approach in ascending aortic dissection based on patient factors and the anatomic
characteristics of the dissection.
Surgery for Congenital
Heart Disease (CHD)
435 Bloodstream infections after median sternotomy at a children’s hospital
Samir S. Shah, MD, Jessica Kagen, BA, Ebbing Lautenbach, MD, MPH, MSCE,
Warren B. Bilker, PhD, Jennifer Matro, BA, Troy E. Dominguez, MD,
Sarah Tabbutt, MD, PhD, J. William Gaynor, MD, and Louis M. Bell, MD, Philadelphia, Pa
Postoperative BSI is a major source of morbidity and increased health care costs. Postoperative
BSI occurred in 6.3% of children undergoing median sternotomy. Postoperative mediastinitis
and the requirement for extracorporeal membrane oxygenation were risk factors for BSI.
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441 Profiles of hemodynamics and oxygen transport derived by using continuous
measured oxygen consumption after the Norwood procedure
Jia Li, MD, PhD, Gencheng Zhang, MD, PhD, Brian W. McCrindle, MD, MPH,
Helen Holtby, MBBS, Tilman Humpl, MD, Sally Cai, MS, Christopher A. Caldarone, MD,
Andrew N. Redington, MD, and Glen S. Van Arsdell, MD, Toronto, Ontario, Canada
Accurate measurement of hemodynamics and oxygen transport allows analysis of the complex
physiology of neonates after the Norwood procedure. A decrease in oxygen consumption (VO2)
during the first 24 hours is the main contributor to improving the balance of oxygen transport
when systemic blood flow and systemic oxygen delivery (DO2) are low. DO2 is most closely
correlated with systemic vascular resistance (SVR) and, to a lesser extent, with the hemoglobin
(Hb) value. Postoperative management strategies to maintain a low VO2, a high Hb value, and
a controlled SVR appear to be rational.
449 Intellectual, neuropsychological, and behavioral functioning in children with
tetralogy of Fallot
Marijke Miatton, Dpsych, Danie¨l De Wolf, MD, PhD, Katrien Franc¸ois, MD,
Evert Thiery, MD, and Guy Vingerhoets, PhD, Ghent, Belgium
The purpose of this study was to define the midterm outcome of children with tetralogy of
Fallot 6 to 12 years postoperatively. We identified a lower estimated full-scale intelligence than
in healthy peers and mild motor and language deficits. Parents indicated attention problems and
lower school competencies.
456 Anomalous origin of the right coronary artery: Right internal thoracic
artery to right coronary artery bypass is not the answer
Lynn M. Fedoruk, MD, John A. Kern, MD, Benjamin B. Peeler, MD, and Irving L. Kron, MD,
Charlottesville, Va
Anomalous origin of the right coronary artery is a lethal congenital anomaly. Attempted
therapy with right internal thoracic artery grafting to the right coronary artery is prone to
failure. Alternative surgical options are described.
461 The aortic translocation (Nikaidoh) procedure: Midterm results superior to
the Rastelli procedure
Thomas Yeh Jr, MD, PhD, Claudio Ramaciotti, MD, Steven R. Leonard, MD,
Lonnie Roy, PhD, and Hisashi Nikaidoh, MD, Dallas, Tex
Longitudinal survival after the Rastelli procedure for ventriculoarterial discordance, ventricular
septal defect, and pulmonary stenosis has been disappointing. Midterm actuarial survival after
the Nikaidoh procedure is 95% (median follow-up 13.6 years), and no important aortic
insufficiency or left ventricular outflow tract obstruction has resulted.
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470 Clinical condition at mid-to-late follow-up after transatrial–transpulmonary
repair of tetralogy of Fallot
Jochem van den Berg, MD, Wim C. Hop, PhD, Jan L. M. Strengers, MD, PhD,
Johan C. de Jongste, MD, PhD, Lennie van Osch-Gevers, MD, PhD,
Folkert J. Meijboom, MD, PhD, Peter M. T. Pattynama, MD, PhD,
Ad J. J. C. Bogers, MD, PhD, and Willem A. Helbing, MD, PhD,
Rotterdam and Utrecht, The Netherlands
This cross-sectional study prospectively assessed clinical condition in 59 patients with TOF
corrected by a transatrial–transpulmonary approach before the age of 2. Clinical condition
appears well preserved, despite RV dilation and dysfunction and associated mild impairment of
functional capacity in one third of patients. Abnormalities relate to RVOT motion
abnormalities, longer interval since repair, longer QRS duration, and more severe PR.
Evolving Technology
(ET)
478 Angiogenic pretreatment to enhance myocardial function after cellular
cardiomyoplasty with skeletal myoblasts
Mauricio A. Retuerto, BS, James T. Beckmann, BS, JoAnn Carbray, BS,
Gerald Patejunas, PhD, Sorin Sarateanu, MD, Bonnie J. Kane, BS, Beverly Smulevitz, BS,
David D. McPherson, MD, and Todd K. Rosengart, MD, Evanston and Chicago, Ill
The hypothesis was that pretreatment of infarcted myocardium with adenovirus encoding VEGF
would enhance survival of subsequently implanted skeletal myoblast implants, enhancing
ventricular function. Implant survival was increased with adenovirus administration 3 weeks
before or simultaneous with myoblast implantation, but left ventricular ejection fraction was




485 Gaseous and solid cerebral microembolization during proximal aortic
anastomoses in off-pump coronary surgery: The effect of an aortic side-
biting clamp and two clampless devices
Lorenzo Guerrieri Wolf, MD, Yasir Abu-Omar, MRCS, Bikram P. Choudhary, MRCS,
David Pigott, FRCA, and David P. Taggart, MD (Hons), PhD, FRCS, Oxford, United Kingdom
Intraoperative cerebral microembolization correlates with subtle forms of cerebral injury such
as neurocognitive decline. Cardiopulmonary bypass and aortic manipulation are the main
sources of intraoperative cerebral microemboli. The use of clampless proximal anastomotic
devices minimizes the solid microembolic load to the brain.
494 Orally administered penicillamine as a potent inhibitor of neointimal and
medial thickening in porcine saphenous vein–carotid artery interposition
grafts
Song Wan, FRCS, Nilima Shukla, PhD, Anthony P. C. Yim, FRCS, Jason L. Johnson, PhD,
Gianni D. Angelini, FRCS, and Jamie Y. Jeremy, PhD, Hong Kong, China, and Bristol, UK
In a pig model, oral administration of penicillamine elicited a potent inhibitory effect on vein
graft thickening and promoted positive remodeling through negation of copper-induced cell
proliferation. Copper chelators may therefore be therapeutically useful in preventing late vein
graft failure in patients undergoing reconstructive coronary arterial surgery.
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501 The safety of moderate hypothermic lower body circulatory arrest with
selective cerebral perfusion: A propensity score analysis
Hiroyuki Kamiya, MD, Christian Hagl, MD, Irina Kropivnitskaya, Dietmar Bo¨thig, MD,
Klaus Kallenbach, MD, Nawid Khaladj, MD, Andreas Martens, MD, Axel Haverich, MD, and
Matthias Karck, MD, Hannover, Germany
Moderate lower body circulatory arrest can be performed safely for aortic arch repair.
Postoperative inflammatory response tends to be lower in patients with moderate lower body
circulatory arrest than in those with deep lower body circulatory arrest, which is a strong risk
factor for reexploration for bleeding.
510 Six-minute walk distance as parameter of functional outcome after
pulmonary endarterectomy for chronic thromboembolic pulmonary
hypertension
Herre J. Reesink, MD, Mart N. van der Plas, MSc, RFT, Niesje E. Verhey, RFT,
Reindert P. van Steenwijk, MD, Jaap J. Kloek, MD, and Paul Bresser, MD, PhD, Amsterdam,
The Netherlands
In chronic thromboembolic pulmonary hypertension, the 6-minute walk distance correlated with
clinical and hemodynamic disease severity. One year after pulmonary endarterectomy, the
observed significant increase in 6-minute walk distance correlated with the postoperative
hemodynamic outcome. In patients with residual pulmonary hypertension, the 6-minute walk
distance was lower than in hemodynamically normalized patients.
517 Vascular pulsatility in patients with a pulsatile- or continuous-flow
ventricular assist device
Adam R. Travis, BE, Guruprasad A. Giridharan, PhD, George M. Pantalos, PhD,
Robert D. Dowling, MD, Sumanth D. Prabhu, MD, Mark S. Slaughter, MD, Mike Sobieski, RN,
Akif Undar, PhD, David J. Farrar, PhD, and Steven C. Koenig, PhD, Louisville, Ky, Oak
Lawn, Ill, Hershey, Pa, and Pleasanton, Calif
Hemodynamic data collected intraoperatively in patients with heart failure undergoing left
ventricular assist device (LVAD) implantation were used to evaluate waveform pulsatility
generated by continuous- and pulsatile-flow LVAD. Although the pulsatile-flow LVAD restored
pulsatility to normal, continuous-flow LVAD diminished pulsatility to nonphysiologic levels,
even at low LVAD flow rates.
Cardiothoracic
Transplantation (TX)
525 Impact of donors aged 60 years or more on outcome after lung
transplantation: Results of an 11-year single-center experience
Marc De Perrot, MD, MSc, Thomas K. Waddell, MD, PhD, Yaron Shargall, MD,
Andrew F. Pierre, MD, MSc, Elie Fadel, MD, Karl Uy, MD, Cecilia Chaparro, MD,
Michael Hutcheon, MD, Lianne G. Singer, MD, and Shaf Keshavjee, MD, MSc, Toronto,
Canada
This study demonstrates that lungs from donors aged 60 years or more can be considered for
transplantation. An evaluation of the postoperative risk should, however, be performed on the
basis of donor characteristics and recipient diagnosis.
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532 Surgical patient outcomes after the increased use of bilateral lung
transplantation
Andrew C. Chang, MD, Kevin M. Chan, MD, Robert J. Lonigro, MS, Christine L. Lau, MD,
Vibha N. Lama, MD, Kevin R. Flaherty, MD, MS, Ros Florn, RN, Allan Pickens, MD,
Susan Murray, ScD, Fernando J. Martinez, MD, MS, and Mark B. Orringer, MD, Ann Arbor, Mich
A single-center experience in lung transplantation is reviewed, with evaluation of outcomes
after bilateral and single lung transplantation and emphasis on listing diagnosis in the context
of the recent implementation of the lung allocation system in the United States.
541 Impact of bilateral versus single lung transplantation on survival in
recipients 60 years of age and older: Analysis of United Network for Organ
Sharing database
Lois U. Nwakanma, MD, Christopher E. Simpkins, MD, Jason A. Williams, MD,
David C. Chang, PhD, MPH, MBA, Marvin C. Borja, BS, John V. Conte, MD, and
Ashish S. Shah, MD, Baltimore, Maryland
The procedure of choice, single (SLT) versus bilateral (BLT) lung transplantation for patients
who are 60 years or older, is unclear. Our analysis of the UNOS database showed that the
survival of lung transplant recipients in this age group who underwent BLT versus SLT is
comparable. Recipients older than 60 years should not be excluded from the use of BLT based
on concerns of higher early mortality.
548 Efficacy and safety of inhaled tacrolimus in rat lung transplantation
Noboru Ide, MD, Takeshi Nagayasu, MD, Keitarou Matsumoto, MD, Tsutomu Tagawa, MD,
Kenji Tanaka, MD, Tsunenori Taguchi, MD, Yorihisa Sumida, MD, and
Mikiro Nakashima, PhD, Nagasaki, Japan
Local immunotherapy with inhaled tacrolimus prevents acute pulmonary rejection and offers
effective allograft drug concentrations with low systemic drug delivery. Thus the local delivery
of tacrolimus has great potential for controlling and treating pulmonary rejection in clinical
lung allograft recipients.
554 The effect of ischemic time on survival after heart transplantation varies by
donor age: An analysis of the United Network for Organ Sharing database
Mark J. Russo, MD, MS, Jonathan M. Chen, MD, Robert A. Sorabella, BA,
Timothy P. Martens, MD, Mauricio Garrido, MD, Ryan R. Davies, MD, Isaac George, MD,
Faisal H. Cheema, MD, Ralph S. Mosca, MD, Seema Mital, MD, Deborah D. Ascheim, MD,
Michael Argenziano, MD, Allan S. Stewart, MD, Mehmet C. Oz, MD, and
Yoshifumi Naka, MD, PhD, New York, NY
This study demonstrates that the effect of ischemic time on posttransplant survival is dependent
on donor age, with greater tolerance for prolonged ischemic times among grafts from younger
donors. Therefore, both donor age and anticipated ischemic time must be considered when
assessing the suitability of a potential donor.
Brief Communications 560 Six stitches to create a neosinus in David-type aortic root resuspension
Anton Moritz, MD, PhD, Petar Risteski, MD, Selami Dogan, MD, Hakan Macit, MD,
Birkan Akbulut, MD, Andreas Zierer, MD, and Tayfun Aybek, MD, Frankfurt, Germany, and
Ankara, Turkey
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562 An entirely endovascular approach to the repair of an ascending aortic
pseudoaneurysm
Firas F. Mussa, MD, Scott A. LeMaire, MD, John Bozinovski, MD, and Joseph S. Coselli, MD,
Houston, Tex
564 Coincidence of aortic valve stenosis and regurgitation and multiple cardiac
papillary fibroelastomas in a young male adult
Karsten Sydow, MD, Sonja Schrepfer, MD, Olaf Franzen, MD, Christian Detter, MD,
Stephan Willems, MD, Thomas Meinertz, MD, and Hermann Reichenspurner, MD, PhD,
Hamburg, Germany
565 Facile conversion from mechanical to bioprosthetic composite aortic root
replacement
Luca A. Vricella, MD, and Duke E. Cameron, MD, Baltimore, Md
567 Bovine jugular vein as a shaped alternative patch material for aortic
augmentation in the Norwood procedure
David G. Healy, MRCSI, Lars Nolke, FRCSI, and Alfred E. Wood, FRCSI, Dublin, Ireland
569 Neoaortic root dilatation with saccular aneurysm formation after the arterial
switch operation for Taussig–Bing anomaly
Yoshitaka Hayashi, MD, PhD, Andrew D. Cochrane, MBBS, FRACS,
Samuel Menahem, MD, BS, FRACP, FACC, FCSANZ, and Julian A. Smith, MS, FRACS,
Clayton, Victoria, Australia
572 Congenital mitral stenosis: A rare presentation and novel approach to
management
Rachel Pase Sosland, MD, James L. Vacek, MD, and Michael E. Gorton, MD, Kansas City,
Kan
573 A novel approach to the surgical correction of scimitar syndrome
Tuan T. Lam, MD, Brian L. Reemtsen, MD, Vaughn A. Starnes, MD, and
Winfield J. Wells, MD, Los Angeles, Calif
575 Circulatory support with attenuated pulse pressure alters human aortic wall
morphology
Stephen Westaby, FRCS, MS, PhD, FETCS, FESC, FACC, FICA, Gabriele B. Bertoni, MD,
Colin Clelland, FRCPath, Tomohiro Nishinaka, MD, PhD, and O. H. Frazier, MD, Oxford,
United Kingdom, and Houston, Tex
577 Elective transfer from cardiopulmonary bypass to centrifugal blood pump
support in very high-risk cardiac surgery
Stephen Westaby, BSc, FRCS, MS, PhD, FETCS, FESC, FACC, FICA,
Lognathen Balacumaraswami, MBBS, FRCS, FRCS (CTh), Betsy J. Evans, MRCS,
Gabriele B. Bertoni, MD, Xu Y. Jin, MD, PhD, Desiree Robson, RN, and
Catherine R. Grebenik, MD, Oxford, UK
579 A novel surgical approach to close an acute ventricular septal defect using
an occluder device
Chanaka Rajakaruna, MRCS, Jonathan Hill, MA, MRCP,
Eleanor Jane Holland Turner, BSc, PhD, MRCS, Alex Sirker, MRCP, Bushra S. Rana, MRCP,
and Olaf Wendler, MD, PhD, FRCS, London, United Kingdom
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581 Inkwelling increases benign stricture formation after Ivor Lewis
esophagogastrectomy
Enoch Akowuah, MD, MRCS, Manfred Junemann-Ramirez, FRCS,
Odunayo Kalejayie, MBCHB, and Joseph Rahamim, FRCS, Plymouth, Devon, United Kingdom
582 Tuberculosis presenting as an endobronchial mass
Daniel Kreisel, MD, PhD, Nimmi Arora, MD, Scott A. Weisenberg, MD, Anjali Saqi, MD,
Alexander S. Krupnick, MD, Anna M. Demetriades, MD, Chris Iakovou, MD,
Rick Conetta, MD, and Paul C. Lee, MD, St Louis, Mo, and New York, NY
584 Lymphoceles in premature infants after congenital diaphragmatic hernia
repair: Thoracoscopic management
Amulya K. Saxena, MD, Emir Haxihja, MD, Barbara Kleinlein, MD, and
Michael E. Ho¨llwarth, MD, Graz, Austria
586 Mediastinal mass: A diagnostic conundrum
Vamsidhar Rachapalli, MRCS, Anil John, FRCS, and Michael J. Unsworth-White, FRCS (CTh),
Plymouth, United Kingdom
587 Bone or pleura? Primary pleural osteosarcoma
Pankaj Chandak, MRCS(Eng), Ian Hunt, MRCS(Eng), Randolph Rawlins, FRCS,
Sebastian Lucas, FRCPath, and Tom Treasure, MD, MS, FRCS, London, United Kingdom
588 Harm from seat belt: Transthoracic lung herniation and pericardial rupture
Christoph Benckert, MD, Armin Thelen, MD, Robert Pfitzmann, MD, Bernhard Gebauer, MD,
Antonino Spinelli, MD, Sven Jonas, MD, and Peter Neuhaus, MD, Berlin, Germany
Letters to the Editor 590 CorCap device in addition to mitral surgery in heart failure: Is it truly
beneficial?
Amir Elami, MD, Jerusalem, Israel
590 Microbiologically documented nosocomial infections after coronary artery
bypass surgery without cardiopulmonary bypass
Dominique M. Vandijck, RN, MSc, MA, Stijn I. Blot, RN, MSc, PhD, and
Jan I. Poelaert, MD, PhD, Ghent, Belgium
591 Reply
Matthew E. Falagas, MD, DSc, Evangelos S. Rosmarakis, MD, and Sotirios N. Prapas, MD,
Athens, Greece, and Boston, Mass
592 Superior vena cava replacement for lung cancer using a heterologous
(bovine) prosthesis: Preliminary results
Federico Rea, MD, Giuseppe Marulli, MD, and Francesco Sartori, MD, Padua, Italy
592 Intraoperative indocyanine green angiography: Ready for prime time?
Alexander Kulik, MD, Fraser D. Rubens, MD, MSc, and Marc Ruel, MD, MPH, Ottawa,
Ontario, Canada
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